journal article text

Supplementary Figure 6 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Abstract

mTORC1/2 inhibition in combination with cisplatin in TC PDX models</p

    Similar works

    Full text

    thumbnail-image